An approach to the design of a particulate system for oral protein delivery. I. In vitro stability of various poly (α-hydroxy acids)-microspheres in simulated gastrointestinal fluids

References

• Allemann E, Leroux J, Gurny R. Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics. Adv Drug Del Rev 1998; 34: 171–189
   PubMed Web of Science ®Google Scholar
• Anderson JM, Shive MS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Del Rev 1997; 28: 5–24
   PubMed Web of Science ®Google Scholar
• Belbella A, Fessi H, Devissaguet JP, Puisieux F. In vitro degradation of nanospheres from poly (D,L-lactides) of different molecular weights and polydispersities. Int J Pharm 1996; 129: 95–102
   Web of Science ®Google Scholar
• Bibby DC, Davis NM, Tucker IG. Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems. Int J Pharm 2000; 197: 1–11
   PubMed Web of Science ®Google Scholar
• Cai Q, Shi G, Bei J, Wang S. Enzymatic degradation behavior and mechanism of poly(lactide-co-glycolide) foams by trypsin. Biomaterials 2003; 24: 629–638
   PubMed Web of Science ®Google Scholar
• Charman WN, Porter CJH, Mithani S, Dressman JB. Physicochemical and physiological mechanisms for the effects of food on drug absorption: The role of lipids and pH. J Pharm Sci 1997; 86: 269–282
   PubMed Web of Science ®Google Scholar
• Chen H, Langer R. Oral particulate delivery: Status and future trends. Adv Drug Del Rev 1998; 34: 339–350
   PubMed Web of Science ®Google Scholar
• Cheng H, Rao Gadder R. Stability-indicating high-performance liquid chromatographic assay for lactic acid in lotions. J Chromatography A 1986; 355: 399–406
   Google Scholar
• Dai C, Wang B, Zhao H. Microencapsulation peptide and protein drugs delivery system. Colloids Surf B Biointerfaces 2005; 41: 117–120
   PubMed Web of Science ®Google Scholar
• Delie F. Evaluation of nano- and microparticle uptake by the gastrointestinal tract. Adv Drug Del Rev 1998; 34: 221–233
   PubMed Web of Science ®Google Scholar
• Delie F, Blanco-Prieto MJ. Polymeric particulates to Improve oral bioavailability of peptide drugs. Molecules 2005; 10: 65–80
   PubMed Web of Science ®Google Scholar
• Desai MP, Labhasetwar V, Walter E, Levy RJ, Amidon GL. The mechanism of uptake biodegradable microparticles in Caco-2 cells is size dependent. Pharm Res 1997; 14: 1568–1573
   PubMed Web of Science ®Google Scholar
• Florence AT. The oral absorption of micro- and nanoparticulates: Neither exceptional nor unusual. Pharm Res 1997; 14: 259–266
   PubMed Web of Science ®Google Scholar
• Haschke-Becher E, Baumgartner M, Bachmann C. Assay of D-lactate in urine of infants and children with reference values taking into account data below detection limit. Clin Chim Acta 2000; 298: 99–109
   PubMed Web of Science ®Google Scholar
• Huang W, Lin C, Huang M, Wen K. Determination of a-hydroxy acids in cosmetics. J Food Drug Anal 2002; 2002: 95–100
   Google Scholar
• Hussain N, Jaitley V, Florence AT. Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. Adv Drug Del Rev 2001; 50: 107–142
   PubMed Web of Science ®Google Scholar
• Jain RA. The manufacturing techniques of various drug loaded biodegradable poly (lactide-co-glycolide) (PLGA) devices. Biomaterials 2000; 21: 2475–2490
   PubMed Web of Science ®Google Scholar
• Jani P, Halbert GW, Langridge J, Florence AT. Nanoparticle uptake by the rat gastrointestinal mucosa: Quantitation and particle size dependency. J Pharm Pharmacol 1990; 42: 821–826
   PubMed Web of Science ®Google Scholar
• Jepsona MA, Clark MA, Hirstb BH. M cell targeting by lectins: A strategy for mucosal vaccination and drug delivery. Adv Drug Del Rev 2004; 56: 511–525
   PubMedGoogle Scholar
• Kiss E, Vargha-Butler EI. Novel method to characterize the hydrolytic decomposition of biopolymer surfaces. Colloids Surf B Biointerfaces 1999; 15: 181–193
   Web of Science ®Google Scholar
• Landry FB, Bazile DV, Spenlehauer G, Veillard M, Kreuter J. Degradation of poly (D,L-lactic acid) nanoparticles coated with albumin in model digestive fluids (USP XXII). Biomaterials 1996; 17: 715–723
   PubMed Web of Science ®Google Scholar
• Lavelle EC, Sharif S, Thomas NW, Holland J, Davis SS. The importance of gastrointestinal uptake of particles in the design of oral delivery systems. Adv Drug Del Rev 1995; 18: 5–22
   Web of Science ®Google Scholar
• McClean S, Prosser E, Meehan E, O’Malley D, Clarke N, Ramtoola Z, Brayden D. Binding and uptake of biodegradable poly-Dl-Lactide micro- and nanoparticles in intestinal epithelia. Eur J Pharm Sci 1998; 6: 153–163
   PubMed Web of Science ®Google Scholar
• Noris DA, Puri N, Sinko PJ. The effect of physical barriers and properties on the oral absorption of particulates. Adv Drug Del Rev 1998; 34: 135–154
   PubMedGoogle Scholar
• Omole OO, Brocks DR, Nappert G, Naylor JM, Zello GA. High-performance liquid chromatographic assay of (±)-lactic acid and its enantiomers in calf serum. J Chromatography B 1999; 727: 23–29
   PubMedGoogle Scholar
• Qiu Y, Zhang G. Research and development aspects of oral controlled-release dosage forms. Handbook of pharmaceutical controlled release technology, DL Wise. Marcel Dekker, New York 2000; 465–503
   Google Scholar
• Rafati H, Coombes AGA, Alder J, Holland J, Davis SS. Protein-loaded poly (DL-lactide-co-glycolide) microparticles for oral administration: Formulation, structural and release characteristics. J Contr Rel 1997; 43: 89–102
   Web of Science ®Google Scholar
• Reich G. In vitro stability of poly (D,L-Lactide) and poly (D,L-lactide)/poloxamer nanoparticles in gastrointestinal fluids. Drug Del Ind Pharm 1997; 23: 1191–1200
   Web of Science ®Google Scholar
• Sinko PJ, Succi G, Lee YH. Non-invasive peptide and protein delivery. Encyclopedia of pharmaceutical technology, J Swarbrick, JC Boylan. Marcel Dekker, Basel 2002; 1883–1900
   Google Scholar
• Tobio M, Sanchez A, Vila A, Soriano I, Evora C, Vila-Jato JL, Alonso MJ. The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration. Colloid Surf B 2000; 18: 311–323
   Google Scholar
• United State Pharmacopeia 27. National Formulary 22. United States Pharmacopeial Convention, Inc., Rockville, MD 2005
   Google Scholar
• Vert M, Schwach G, Engel R, Coudane J. Something new in the field of PLA/GA biosorbable polymers?. J Contr Rel 1998; 53: 85–92
   PubMed Web of Science ®Google Scholar
• Yeh P, Ellens H, Smith PL. Physiological consideration in the design of particulate dosage forms for oral vaccine delivery. Adv Drug Del Rev 1998; 34: 123–133
   PubMed Web of Science ®Google Scholar